These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15743501)

  • 1. Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study.
    Benusiglio PR; Lesueur F; Luccarini C; Conroy DM; Shah M; Easton DF; Day NE; Dunning AM; Pharoah PD; Ponder BA
    Breast Cancer Res; 2005; 7(2):R204-9. PubMed ID: 15743501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
    Benusiglio PR; Lesueur F; Luccarini C; McIntosh J; Luben RN; Smith P; Dunning A; Easton DF; Ponder BA; Pharoah PD
    BMC Cancer; 2005 Jul; 5():81. PubMed ID: 16029503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer.
    Benusiglio PR; Pharoah PD; Smith PL; Lesueur F; Conroy D; Luben RN; Dew G; Jordan C; Dunning A; Easton DF; Ponder BA
    Br J Cancer; 2006 Dec; 95(12):1689-95. PubMed ID: 17117180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heritable variation of ERBB2 and breast cancer risk.
    Breyer JP; Sanders ME; Airey DC; Cai Q; Yaspan BL; Schuyler PA; Dai Q; Boulos F; Olivares MG; Bradley KM; Gao YT; Page DL; Dupont WD; Zheng W; Smith JR
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1252-8. PubMed ID: 19336545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects.
    Hunt SC; Hasstedt SJ; Xin Y; Dalley BK; Milash BA; Yakobson E; Gress RE; Davidson LE; Adams TD
    Obesity (Silver Spring); 2011 Nov; 19(11):2241-7. PubMed ID: 21818152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.
    Wang H; Liu L; Lang Z; Guo S; Gong H; Guan H; Zhang J; Liu B
    J Surg Oncol; 2013 Nov; 108(6):337-41. PubMed ID: 23900832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms.
    Kawasaki A; Kyogoku C; Ohashi J; Miyashita R; Hikami K; Kusaoi M; Tokunaga K; Takasaki Y; Hashimoto H; Behrens TW; Tsuchiya N
    Arthritis Rheum; 2008 Mar; 58(3):826-34. PubMed ID: 18311811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 genotypes and haplotypes associated with risk of breast cancer.
    Buyru N; Altinisik J; Demokan S; Dalay N
    Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.
    Qiu Y; Zhang ZY; Du WD; Ye L; Xu S; Zuo XB; Zhou FS; Chen G; Ma XL; Schneider ME; Xia HZ; Zhou Y; Wu JF; Yuan-Hong X; Zhang XJ
    Gene; 2014 Feb; 535(2):225-32. PubMed ID: 24291029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.
    Tommasi S; Fedele V; Lacalamita R; Bruno M; Schittulli F; Ginzinger D; Scott G; Eppenberger-Castori S; Calistri D; Casadei S; Seymour I; Longo S; Giannelli G; Pilato B; Simone G; Benz CC; Paradiso A
    Cell Oncol; 2007; 29(3):241-8. PubMed ID: 17452776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population.
    Lesueur F; Song H; Ahmed S; Luccarini C; Jordan C; Luben R; Easton DF; Dunning AM; Pharoah PD; Ponder BA
    Br J Cancer; 2006 Jun; 94(12):1921-6. PubMed ID: 16685266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.
    Andersson U; Schwartzbaum J; Wiklund F; Sjöström S; Liu Y; Tsavachidis S; Ahlbom A; Auvinen A; Collatz-Laier H; Feychting M; Johansen C; Kiuru A; Lönn S; Schoemaker MJ; Swerdlow AJ; Henriksson R; Bondy M; Melin B
    Acta Oncol; 2010 Aug; 49(6):767-75. PubMed ID: 20446891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women.
    Howard TD; Giles WH; Xu J; Wozniak MA; Malarcher AM; Lange LA; Macko RF; Basehore MJ; Meyers DA; Cole JW; Kittner SJ
    Stroke; 2005 Sep; 36(9):1848-51. PubMed ID: 16100023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of polymorphisms and haplotypes in the insulin-like growth factor 1 receptor (IGF1R) gene with the risk of breast cancer in Korean women.
    Kang HS; Ahn SH; Mishra SK; Hong KM; Lee ES; Shin KH; Ro J; Lee KS; Kim MK
    PLoS One; 2014; 9(1):e84532. PubMed ID: 24392142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotypes of intron 4 of the estrogen receptor alpha gene and hip fractures: a replication study in Caucasians.
    Velasco J; Hernández JL; Pérez-Castrillón JL; Zarrabeitia MT; Alonso MA; González-Macías J; Riancho JA
    BMC Med Genet; 2010 Jan; 11():16. PubMed ID: 20109228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between HER2 and IL-6 genes polymorphisms and clinicopathological characteristics of breast cancer: significant role of genetic variability in specific breast cancer subtype.
    Bouhniz OE; Zaied S; Naija L; Bettaieb I; Rahal K; Driss M; Kenani A
    Clin Exp Med; 2020 Aug; 20(3):427-436. PubMed ID: 32372374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.